Comparison of Efficacy and Safety of Combination Therapy and Monotherapy of Candesartan and Amlodipine for Dose-Finding in Patients With Essential Hypertension

PHASE2CompletedINTERVENTIONAL
Enrollment

392

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Essential Hypertension
Interventions
DRUG

Candesartan Cilexetil 8mg

Candesartan Cilexetil 8mg Daily oral administration for 8 weeks

DRUG

Candesartan Cilexetil 16mg

Candesartan Cilexetil 16mg Daily oral administration for 8 weeks

DRUG

Amlodipine 5mg

Amlodipine 5mg Daily oral administration for 8 weeks

DRUG

Amlodipine 10mg

Amlodipine 10mg Daily oral administration for 8 weeks

Trial Locations (23)

Unknown

Catholic University of Korea Bucheon St. Mary's Hospital, Wonmi-gu

Inje University Busan Paik Hospital, Busanjin-gu

Pusan National University Hospital, Seo-gu

Keimyung University Dongsan Medical Center, Joong-gu

Kyungpook National University Hospital, Joong-gu

Daegu Catholic University Medical Center, Nam- Gu

Wonju Severance Christian Hospital, Wŏnju

Dongguk University Ilsan Hospital, Ilsandong-gu

Chonnam National University Hospital, Dong-Gu

Catholic University of Korea Uijeongbu St. Mary's hospital, Uijeongbu-si

Gachon University Gil Hospital, Namdong-gu

St. Carollo General Hospital, Suncheon-si

Catholic University of Korea St. Paul's Hospital, Dongdaemun-gu

KyungHee University Medical Center, Dongdaemun-gu

Hallym University Kangdong Sacred Heart Hospital, Gangdong-gu

Kyung Hee University Hospital at Gangdong, Gangdong-Gu

VHS( Veterans Medical Service) Medical Center, Gangdong-gu

Konkuk University Medical Center, Gwangjin-gu

Seoul National University Hospital, Jongro-gu

Catholic University of Korea Seoul St. Mary's Hospital, Seocho-Gu

Korea University Anam Hospital, Seongbuk-Gu

Catholic University of Korea Yeouido St. Mary's Hospital, Yeongdeungpo-gu

Ulsan University Hospital, Dong-gu

All Listed Sponsors
lead

Shin Poong Pharmaceutical Co. Ltd.

INDUSTRY

NCT02944734 - Comparison of Efficacy and Safety of Combination Therapy and Monotherapy of Candesartan and Amlodipine for Dose-Finding in Patients With Essential Hypertension | Biotech Hunter | Biotech Hunter